TAYEH CAPITAL GROUP
TAYEH CAPITAL GROUP is a Series C+ fund in the US investing in Healthcare, business-services, professional-services, industrial-services and life-sciences.
- Stages
- Series C+
- Sectors
- Healthcare, business-services, professional-services, industrial-services, life-sciences
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2025
- Assets under management
- $800M
Check size not disclosed
Thesis
The firm operates with a relationship-based and growth-focused strategy, aiming to build enduring value in the middle market. TCG primarily partners with founders and management teams of family-owned, rapidly growing middle-market companies, with a particular emphasis on the business services sector, including professional and industrial services, biotech, and life sciences. Their investment thesis centers on companies with strong fundamentals that benefit from secular tailwinds. The firm's inaugural fund, backed by GCM Grosvenor's Elevate Fund, completed its final close in December 2024 with nearly $800 million in committed capital. TCG emphasizes a 'round-table mindset,' human capital focus, and a principled, forward-thinking approach. While specific deal sizes are not stated, investments are expected to be in the tens to hundreds of millions of dollars, reflecting their middle-market focus and fund size. The firm has offices in New York, Detroit, and Los Angeles.
Common questions
Does TAYEH CAPITAL GROUP invest at the Series C+ stage?
Yes. TAYEH CAPITAL GROUP lists Series C+ among the stages it invests in.
Where does TAYEH CAPITAL GROUP invest?
TAYEH CAPITAL GROUP invests in the US.